2m 2m 2m 2m 2m 2m 2m
Baxter Intl (BAX)
NYSE
$22.66+$0.09 (+0.40%)
Price as of Jul 13, 2026 7:58 PM EDT- $11.7BMarket Cap
- -20.21%1-Year Change
- Medical Instruments & SuppliesIndustry
Baxter Intl (BAX)
$22.66+$0.09 (+0.40%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 11.2B +5.72% | 10.6B -28.20% | 14.8B -1.99% | 15.1B +18.22% | |
Cost of Revenue | 7.9B +18.24% | 6.7B -32.38% | 9.8B +1.26% | 9.7B +26.53% | |
Gross Profit | 3.4B -15.19% | 4.0B -19.92% | 5.0B -7.82% | 5.4B +5.72% | |
Sales and Marketing Expense | 2.9B -2.60% | 3.0B -24.81% | 3.9B +1.52% | 3.9B +35.58% | |
Research and Development Expense | -518.0M -12.20% | -590.0M -11.54% | -667.0M -210.25% | 605.0M +13.30% | |
Depreciation and Amortization Expense | 981.0M -1.60% | 997.0M -21.06% | 1.3B -9.98% | 1.4B +57.64% | |
Total Operating Expenses | 7.9B +18.24% | 6.7B -32.38% | 9.8B +1.26% | 9.7B +26.53% | |
Operating Profit | -308.0M -2,300.00% | 14.0M -96.41% | 390.0M +120.07% | -1.9B -213.63% | |
Interest Income | 52.0M -22.39% | 67.0M -4.29% | 70.0M +250.00% | 20.0M +42.86% | |
Interest Expense | -238.0M -30.21% | -341.0M -22.85% | -442.0M +11.90% | -395.0M +105.73% | |
Interest Income and Expense and Net | -186.0M -32.12% | -274.0M -26.34% | -372.0M -5.82% | -395.0M +105.73% | |
Total Nonoperating Income and Expense | 41.0M +7.89% | 38.0M +174.51% | -51.0M +240.00% | -15.0M -63.41% | |
Income before Taxes | -505.0M +74.74% | -289.0M +180.58% | -103.0M -95.62% | -2.4B -259.31% | |
Income Taxes | 395.0M +967.57% | 37.0M +208.82% | -34.0M -150.00% | 68.0M -62.64% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -957.0M +47.46% | -649.0M -124.44% | 2.7B +209.17% | -2.4B -289.49% | |
Net Income from Continuing Operations Applicable to Common | -505.0M +74.74% | -289.0M +180.58% | -103.0M -95.62% | -2.4B -259.31% | |
Basic EPS and Net Income | -1.87 +47.24% | -1.27 -124.19% | 5.25 +208.70% | -4.83 -288.67% | |
Diluted EPS and Net Income | -1.87 +47.24% | -1.27 -124.19% | 5.25 +208.70% | -4.83 -290.91% | |
Basic Weighted Average Shares | 513.0M +0.59% | 510.0M +0.79% | 506.0M +0.40% | 504.0M +0.40% | |
Diluted Weighted Average Shares | 513.0M +0.59% | 510.0M +0.79% | 506.0M +0.40% | 504.0M -0.79% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 2.0B +11.45% | 1.8B -44.77% | 3.2B +85.91% | 1.7B -41.78% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 2.0B +11.45% | 1.8B -44.77% | 3.2B +85.91% | 1.7B -41.78% | |
Total Current Assets | 6.9B -22.38% | 8.9B -7.78% | 9.6B +19.84% | 8.0B -9.70% | |
Accumulated Depreciation | 5.1B +7.66% | 4.8B -29.63% | 6.8B +5.40% | 6.4B -1.65% | |
Property and Plant and Equipment and Net | 2.9B +1.39% | 2.9B -35.26% | 4.4B -10.97% | 5.0B -3.84% | |
Total Long-Term Assets | 699.0M -7.42% | 755.0M -32.95% | 1.1B +1.35% | 1.1B -8.41% | |
Total Assets | 20.1B -22.21% | 25.8B -8.82% | 28.3B -0.04% | 28.3B -15.61% | |
Income Taxes Payable | 424.0M +32.50% | 320.0M -62.88% | 862.0M -9.45% | 952.0M -22.35% | |
Total Short-Term Debt | 3.0M -99.89% | 2.8B +3.15% | 2.7B +90.03% | 1.4B +174.76% | |
Total Current Liabilities | 3.0B -54.38% | 6.5B +0.12% | 6.5B +37.05% | 4.7B +12.02% | |
Total Long-Term Debt | 28.3B +173.25% | 10.4B -6.79% | 11.1B -77.08% | 48.6B -7.60% | |
Total Long-Term Liabilities | 1.3B +19.61% | 1.1B -38.05% | 1.7B -11.33% | 2.0B -21.42% | |
Total Liabilities | 14.0B -25.62% | 18.8B -5.30% | 19.8B -11.54% | 22.4B -8.23% | |
Retained Earnings | 13.7B -8.20% | 14.9B -7.35% | 16.1B +14.69% | 14.1B -17.67% | |
Total Stockholders Equity | 6.1B -11.99% | 7.0B -17.11% | 8.4B +44.04% | 5.8B -35.74% | |
Total Shares Outstanding | 683.5M 0.00% | 683.5M 0.00% | 683.5M 0.00% | 683.5M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | 845.0M -17.08% | 1.0B -40.96% | 1.7B +42.53% | 1.2B -45.50% | |
Capital Expenditures | 513.0M +15.02% | 446.0M -35.55% | 692.0M +1.91% | 679.0M -8.61% | |
Cash from Investing Activities | 2.8B +553.83% | -626.0M -119.48% | 3.2B +445.11% | -931.0M -91.69% | |
Dividends Paid | 348.0M -41.02% | 590.0M +0.68% | 586.0M +2.27% | 573.0M +8.11% | |
Cash from Financing Activities | -4.2B +290.01% | -1.1B -69.02% | -3.5B +142.63% | -1.4B -117.44% | |
Financials Ratio | |||||
Gross Margin | 30.05% -19.77% | 37.46% +11.53% | 33.59% -5.95% | 35.71% -10.57% | |
Operating Margin | -2.74% -2,181.46% | 0.13% -95.00% | 2.63% +120.48% | -12.86% -196.12% | |
Return on Assets | -4.18% +73.91% | -2.40% -125.57% | 9.39% +219.29% | -7.87% -264.14% | |
Return on Equity | -14.62% +73.06% | -8.45% -122.64% | 37.32% +214.34% | -32.64% -325.78% | |
Revenue Growth | 5.72% +120.27% | -28.20% +1,320.56% | -1.98% -110.90% | 18.22% +91.41% | |
Current Ratio | 2.31 +70.17% | 1.36 -7.89% | 1.48 -12.56% | 1.69 -19.39% | |
Cash Ratio | 0.66 +144.37% | 0.27 -44.85% | 0.49 +35.65% | 0.36 -48.02% | |
Debt-to-Equity Ratio | 4.63 +145.42% | 1.88 +14.77% | 1.64 -80.83% | 8.57 +46.53% | |
Debt-to-Assets Ratio | 1.41 +177.67% | 0.51 +4.32% | 0.49 -72.38% | 1.77 +11.58% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow